Mimesis
Our Mission

Our Mission

SPEED UP OF THE DRUG DISCOVERY PROCESS

Strong reduction of the time required to pass from a preclinical validation to a phase I clinical trial, predicting at the same time the outcome of the phase II clinical trials.

OPTIMIZATION OF CLINICAL STUDIES

Drastic reduction of the number of in vivo experiments, which means significant costs saving.

IMPROVEMENT OF THE DESIGN OF EXISTING EXPERIMENTS

Maximization of the chances of success of in vivo / in vitro experiments and reduction of costs and times for clinical validation.

MODELING NEW EXPERIMENTAL STUDIES

Development of new experimental settings, providing a better prediction of the toxicity profile of medical products.

en why mim